BTN2A1 and cranioectodermal dysplasia: BTN2A1 variants were more frequent in CeD patients, as 45.8% (22/48) of CeD participants had at least one qualifying BTN2A1 variant compared to 10.9% (5/46) of controls (Table 2a,b).